Team

John Josey, PhD
John Josey, PhD
Director

Dr. John Josey is a Partner at The Column Group. He is an accomplished executive and drug discovery leader with expertise spanning medicinal chemistry, oncology, and company creation. Most recently, Dr. Josey served as President and CEO of Peloton Therapeutics, leading the company through its acquisition by Merck in 2019. Prior to becoming CEO, he was Peloton’s first employee. Earlier in his career, Dr. Josey was also a member of the founding management team at Array BioPharma, where he spent more than thirteen years and advanced to Vice President of Discovery Chemistry. Dr. Josey received his PhD in Organic Chemistry from The University of Texas at Austin, his MBA from the University of Colorado, and completed postdoctoral training at the California Institute of Technology.